Postprandial hyperglycemia is a key metabolic disturbance associated with the progression to Type 2 Diabetes Mellitus, highlighting the need for effective preventive strategies. Psidium guajava leaves contain bioactive compounds, including flavonoids, tannins, and polyphenols, that have been investigated for their antihyperglycemic potential. This systematic review, conducted in accordance with PRISMA guidelines, synthesized evidence from 12 included studies comprising two in vitro studies, six in vivo studies, three clinical studies, and one mixed review–experimental study. The findings suggest that guava leaf preparations may attenuate postprandial glycemic responses through complementary mechanisms, including inhibition of carbohydrate-digesting enzymes, enhancement of cellular glucose uptake, improvement of insulin sensitivity, and reduction of oxidative stress. Clinical studies reported reductions in postprandial glucose responses, while experimental investigations provided supporting mechanistic evidence. However, methodological heterogeneity, limited clinical evidence, and uncertainties in study quality restrict the strength of these findings. Overall, Psidium guajava leaf preparations demonstrate potential as a complementary approach to postprandial glycemic management, although further well-designed clinical trials are required to establish their efficacy, optimal dosage, and long-term safety.
Copyrights © 2026